Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
11801
11802
11803
11804
11805
11806
11807
11808
11809
11810
11811
11812
11813
11814
11815
11816
11817
11818
11819
11820
11821
11822
11823
11824
11825
11826
11827
11828
11829
11830
11831
11832
11833
11834
11835
11836
11837
11838
11839
11840
11841
11842
11843
11844
11845
11846
11847
11848
11849
11850
11851
11852
11853
11854
11855
11856
11857
11858
11859
11860
11861
11862
11863
11864
11865
11866
11867
11868
11869
11870
11871
11872
11873
11874
11875
11876
11877
11878
11879
11880
11881
11882
11883
11884
11885
11886
11887
11888
11889
11890
11891
11892
11893
11894
11895
11896
11897
11898
11899
11900
11901
11902
11903
11904
11905
11906
11907
11908
11909
11910
11911
11912
11913
11914
11915
11916
11917
11918
11919
11920
11921
11922
11923
11924
11925
11926
11927
11928
11929
11930
11931
11932
11933
11934
11935
11936
11937
11938
11939
11940
11941
11942
11943
11944
11945
11946
11947
11948
11949
11950
11951
11952
11953
11954
11955
11956
11957
11958
11959
11960
11961
11962
11963
11964
11965
11966
11967
11968
11969
11970
11971
11972
11973
11974
11975
11976
11977
11978
11979
11980
11981
11982
11983
11984
11985
11986
11987
11988
11989
11990
11991
11992
11993
11994
11995
11996
11997
11998
11999
12000
| UnnamedSample_HQ_transcript/41276|m.12111 | UnnamedSample_HQ_transcript/41276 | Coverage 0.582 too low. | 469e033382757294d5647a44ae54a266 | 587 | Pfam | PF00017 | SH2 domain | 428 | 511 | 9.2E-14 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/41276|m.12111 | UnnamedSample_HQ_transcript/41276 | Coverage 0.582 too low. | 469e033382757294d5647a44ae54a266 | 587 | Pfam | PF08947 | BPS (Between PH and SH2) | 365 | 405 | 1.4E-10 | T | 22-09-2020 | IPR015042 | BPS (Between PH and SH2) domain |
| UnnamedSample_HQ_transcript/100425|m.22700 | UnnamedSample_HQ_transcript/100425 | Coverage 0.892 too low. | 4fc539a47e90508df39e2fb7abdafb60 | 333 | Pfam | PF05997 | Nucleolar protein,Nop52 | 19 | 220 | 1.6E-46 | T | 22-09-2020 | IPR010301 | Nucleolar, Nop52 |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 617 | 703 | 5.5E-15 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 47 | 137 | 2.9E-14 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 1126 | 1214 | 3.7E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 379 | 428 | 1.4E-8 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 246 | 325 | 5.0E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 3 | 40 | 2.1E-10 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 918 | 990 | 8.4E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 812 | 896 | 2.6E-16 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 999 | 1084 | 9.4E-12 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 719 | 801 | 2.0E-7 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 144 | 235 | 1.4E-13 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/4268|m.1903 | UnnamedSample_HQ_transcript/4268 | Coverage 0.359 too low. | 3c2ac8ec2d130b708c155bf66be4fea7 | 1217 | Pfam | PF00630 | Filamin/ABP280 repeat | 438 | 520 | 1.0E-18 | T | 22-09-2020 | IPR017868 | Filamin/ABP280 repeat-like |
| UnnamedSample_HQ_transcript/83105|m.20212 | UnnamedSample_HQ_transcript/83105 | Coverage 0.758 too low. | 24642141d7e22327c40e76c6d60f7821 | 176 | Pfam | PF05485 | THAP domain | 54 | 118 | 2.0E-9 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF00008 | EGF-like domain | 531 | 560 | 8.3E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF00008 | EGF-like domain | 953 | 976 | 1.4E-6 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF00754 | F5/8 type C domain | 34 | 159 | 4.3E-21 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF02210 | Laminin G domain | 1019 | 1142 | 2.2E-13 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF02210 | Laminin G domain | 383 | 501 | 3.4E-16 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF02210 | Laminin G domain | 809 | 930 | 1.2E-18 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/8924|m.3488 | UnnamedSample_HQ_transcript/8924 | Coverage 0.932 too low. | 9b86a70f9877fccac0dcd048deeb66a9 | 1269 | Pfam | PF02210 | Laminin G domain | 198 | 318 | 1.8E-24 | T | 22-09-2020 | IPR001791 | Laminin G domain |
| UnnamedSample_HQ_transcript/34309|m.10551 | UnnamedSample_HQ_transcript/34309 | Coverage 0.958 too low. | 5c589e52278487cc823063378ef92c48 | 728 | Pfam | PF03723 | Hemocyanin, ig-like domain | 419 | 674 | 4.1E-82 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/34309|m.10551 | UnnamedSample_HQ_transcript/34309 | Coverage 0.958 too low. | 5c589e52278487cc823063378ef92c48 | 728 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 33 | 139 | 3.9E-18 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/34309|m.10551 | UnnamedSample_HQ_transcript/34309 | Coverage 0.958 too low. | 5c589e52278487cc823063378ef92c48 | 728 | Pfam | PF00372 | Hemocyanin, copper containing domain | 150 | 410 | 2.8E-67 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/40540|m.11969 | UnnamedSample_HQ_transcript/40540 | Identity 0.908 too low. | 5c589e52278487cc823063378ef92c48 | 728 | Pfam | PF03723 | Hemocyanin, ig-like domain | 419 | 674 | 4.1E-82 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/40540|m.11969 | UnnamedSample_HQ_transcript/40540 | Identity 0.908 too low. | 5c589e52278487cc823063378ef92c48 | 728 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 33 | 139 | 3.9E-18 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/40540|m.11969 | UnnamedSample_HQ_transcript/40540 | Identity 0.908 too low. | 5c589e52278487cc823063378ef92c48 | 728 | Pfam | PF00372 | Hemocyanin, copper containing domain | 150 | 410 | 2.8E-67 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/32|m.33 | UnnamedSample_HQ_transcript/32 | Unmapped. | 59ca33313488e35ed8d8ff01860f5fc1 | 1891 | Pfam | PF13086 | AAA domain | 539 | 609 | 9.4E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/32|m.33 | UnnamedSample_HQ_transcript/32 | Unmapped. | 59ca33313488e35ed8d8ff01860f5fc1 | 1891 | Pfam | PF13087 | AAA domain | 722 | 893 | 1.8E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/6643|m.2758 | UnnamedSample_HQ_transcript/6643 | Coverage 0.731 too low. | bd8c4c6701eb6a3fdec3fc8588ba41cc | 553 | Pfam | PF00567 | Tudor domain | 42 | 107 | 1.3E-4 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/6643|m.2758 | UnnamedSample_HQ_transcript/6643 | Coverage 0.731 too low. | bd8c4c6701eb6a3fdec3fc8588ba41cc | 553 | Pfam | PF00567 | Tudor domain | 406 | 487 | 2.8E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/6643|m.2758 | UnnamedSample_HQ_transcript/6643 | Coverage 0.731 too low. | bd8c4c6701eb6a3fdec3fc8588ba41cc | 553 | Pfam | PF00567 | Tudor domain | 204 | 312 | 3.8E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/48440|m.13683 | UnnamedSample_HQ_transcript/48440 | Coverage 0.896 too low. | 9d158df7e6c45435fcf6f0f8ddb9a5d9 | 531 | Pfam | PF00083 | Sugar (and other) transporter | 54 | 491 | 5.4E-88 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/42658|m.12405 | UnnamedSample_HQ_transcript/42658 | Coverage 0.069 too low. | 76f28a85bcee3468228ed55fb2b870bb | 245 | Pfam | PF01044 | Vinculin family | 46 | 216 | 1.9E-16 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/11385|m.4286 | UnnamedSample_HQ_transcript/11385 | Coverage 0.469 too low. | a292a644e4998df2aa096ec023ac3f39 | 286 | Pfam | PF00443 | Ubiquitin carboxyl-terminal hydrolase | 68 | 268 | 4.2E-25 | T | 22-09-2020 | IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase |
| UnnamedSample_HQ_transcript/21205|m.7199 | UnnamedSample_HQ_transcript/21205 | Coverage 0.496 too low. | 7be4a246d0da6637f83df9a9d1c315af | 518 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 160 | 234 | 1.0E-5 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/5995|m.2541 | UnnamedSample_HQ_transcript/5995 | Coverage 0.299 too low. | 8f08565f09122ab2533fc07a3f4a3405 | 565 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 55 | 192 | 1.4E-29 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/5995|m.2541 | UnnamedSample_HQ_transcript/5995 | Coverage 0.299 too low. | 8f08565f09122ab2533fc07a3f4a3405 | 565 | Pfam | PF13976 | GAG-pre-integrase domain | 493 | 544 | 5.2E-8 | T | 22-09-2020 | IPR025724 | GAG-pre-integrase domain |
| UnnamedSample_HQ_transcript/5995|m.2541 | UnnamedSample_HQ_transcript/5995 | Coverage 0.299 too low. | 8f08565f09122ab2533fc07a3f4a3405 | 565 | Pfam | PF00098 | Zinc knuckle | 302 | 316 | 0.0037 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/5995|m.2541 | UnnamedSample_HQ_transcript/5995 | Coverage 0.299 too low. | 8f08565f09122ab2533fc07a3f4a3405 | 565 | Pfam | PF00098 | Zinc knuckle | 283 | 299 | 5.3E-4 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/84484|m.20414 | UnnamedSample_HQ_transcript/84484 | Unmapped. | 46edf642838681b9e1f9cc232492f549 | 427 | Pfam | PF03216 | Rhabdovirus nucleoprotein | 51 | 334 | 1.2E-10 | T | 22-09-2020 | IPR004902 | Rhabdovirus nucleoprotein |
| UnnamedSample_HQ_transcript/45473|m.13026 | UnnamedSample_HQ_transcript/45473 | Coverage 0.104 too low. | 8537d6b19d1e16bfa342d6203177b58c | 426 | Pfam | PF13927 | Immunoglobulin domain | 119 | 179 | 1.5E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/45473|m.13026 | UnnamedSample_HQ_transcript/45473 | Coverage 0.104 too low. | 8537d6b19d1e16bfa342d6203177b58c | 426 | Pfam | PF13927 | Immunoglobulin domain | 200 | 280 | 8.9E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/45473|m.13026 | UnnamedSample_HQ_transcript/45473 | Coverage 0.104 too low. | 8537d6b19d1e16bfa342d6203177b58c | 426 | Pfam | PF07679 | Immunoglobulin I-set domain | 25 | 105 | 2.1E-5 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/197|m.177 | UnnamedSample_HQ_transcript/197 | Unmapped. | 6deda1a07025c09b55e970473b7b52c2 | 1760 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1394 | 1719 | 2.6E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/197|m.177 | UnnamedSample_HQ_transcript/197 | Unmapped. | 6deda1a07025c09b55e970473b7b52c2 | 1760 | Pfam | PF00910 | RNA helicase | 332 | 440 | 6.5E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/98241|m.22401 | UnnamedSample_HQ_transcript/98241 | Unmapped. | ce751f93e1db1387ac09c08c48bd53bb | 314 | Pfam | PF16198 | tRNA pseudouridylate synthase B C-terminal domain | 181 | 247 | 6.7E-22 | T | 22-09-2020 | IPR032819 | tRNA pseudouridylate synthase B, C-terminal |
| UnnamedSample_HQ_transcript/98241|m.22401 | UnnamedSample_HQ_transcript/98241 | Unmapped. | ce751f93e1db1387ac09c08c48bd53bb | 314 | Pfam | PF09157 | Pseudouridine synthase II TruB, C-terminal | 251 | 308 | 2.4E-15 | T | 22-09-2020 | IPR015240 | tRNA pseudouridine synthase II, TruB, subfamily 1, C-terminal |
| UnnamedSample_HQ_transcript/98241|m.22401 | UnnamedSample_HQ_transcript/98241 | Unmapped. | ce751f93e1db1387ac09c08c48bd53bb | 314 | Pfam | PF01509 | TruB family pseudouridylate synthase (N terminal domain) | 33 | 180 | 3.0E-52 | T | 22-09-2020 | IPR002501 | Pseudouridine synthase II, N-terminal |
| UnnamedSample_HQ_transcript/95642|m.22042 | UnnamedSample_HQ_transcript/95642 | Identity 0.942 too low. | 55ca39ff2805ace8c8eb3a61b4d1d325 | 327 | Pfam | PF00035 | Double-stranded RNA binding motif | 59 | 122 | 2.2E-12 | T | 22-09-2020 | IPR014720 | Double-stranded RNA-binding domain |
| UnnamedSample_HQ_transcript/95642|m.22042 | UnnamedSample_HQ_transcript/95642 | Identity 0.942 too low. | 55ca39ff2805ace8c8eb3a61b4d1d325 | 327 | Pfam | PF16482 | Staufen C-terminal domain | 219 | 301 | 2.0E-18 | T | 22-09-2020 | IPR032478 | Staufen, C-terminal |
| UnnamedSample_HQ_transcript/41294|m.12115 | UnnamedSample_HQ_transcript/41294 | Coverage 0.990 too low. | ea1c57db75b3614c14f4d2bc71be4e8a | 740 | Pfam | PF01448 | ELM2 domain | 8 | 62 | 1.5E-8 | T | 22-09-2020 | IPR000949 | ELM2 domain |
| UnnamedSample_HQ_transcript/41294|m.12115 | UnnamedSample_HQ_transcript/41294 | Coverage 0.990 too low. | ea1c57db75b3614c14f4d2bc71be4e8a | 740 | Pfam | PF00320 | GATA zinc finger | 244 | 281 | 1.5E-6 | T | 22-09-2020 | IPR000679 | Zinc finger, GATA-type |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF14604 | Variant SH3 domain | 66 | 111 | 2.8E-8 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF07679 | Immunoglobulin I-set domain | 571 | 644 | 2.0E-7 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF07679 | Immunoglobulin I-set domain | 470 | 559 | 1.4E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF07679 | Immunoglobulin I-set domain | 373 | 459 | 1.1E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF07679 | Immunoglobulin I-set domain | 147 | 237 | 3.2E-23 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF07679 | Immunoglobulin I-set domain | 272 | 365 | 4.6E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/44674|m.12849 | UnnamedSample_HQ_transcript/44674 | Coverage 0.749 too low. | 29918696819ccd35688dbc033326f54e | 746 | Pfam | PF07679 | Immunoglobulin I-set domain | 653 | 738 | 1.3E-12 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/15228|m.5474 | UnnamedSample_HQ_transcript/15228 | Coverage 0.934 too low. | 27fba62dd505e7ba09a74f3fe84c4ae5 | 442 | Pfam | PF02826 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain | 134 | 318 | 3.0E-55 | T | 22-09-2020 | IPR006140 | D-isomer specific 2-hydroxyacid dehydrogenase, NAD-binding domain |
| UnnamedSample_HQ_transcript/15228|m.5474 | UnnamedSample_HQ_transcript/15228 | Coverage 0.934 too low. | 27fba62dd505e7ba09a74f3fe84c4ae5 | 442 | Pfam | PF00389 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain | 39 | 353 | 8.2E-29 | T | 22-09-2020 | IPR006139 | D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain |
| UnnamedSample_HQ_transcript/57651|m.15580 | UnnamedSample_HQ_transcript/57651 | Coverage 0.741 too low. | 9b8469b3057f36fede87b1d7417d7df9 | 230 | Pfam | PF00028 | Cadherin domain | 110 | 203 | 9.9E-16 | T | 22-09-2020 | IPR002126 | Cadherin-like |
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF13912 | C2H2-type zinc finger | 323 | 347 | 0.0075 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF13894 | C2H2-type zinc finger | 109 | 131 | 8.2E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF13894 | C2H2-type zinc finger | 379 | 401 | 2.8E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF00096 | Zinc finger, C2H2 type | 165 | 187 | 0.0019 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF00096 | Zinc finger, C2H2 type | 81 | 103 | 3.9E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF00096 | Zinc finger, C2H2 type | 435 | 457 | 5.7E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF00096 | Zinc finger, C2H2 type | 463 | 486 | 0.0013 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/49663|m.13948 | UnnamedSample_HQ_transcript/49663 | Identity 0.880 too low. | 4f8876b377b086803ac3874421d71f46 | 697 | Pfam | PF00096 | Zinc finger, C2H2 type | 137 | 159 | 6.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/10868|m.4103 | UnnamedSample_HQ_transcript/10868 | Coverage 0.730 too low. | 7a0a3ccadbcf3756a19c96393fb380ee | 353 | Pfam | PF11838 | ERAP1-like C-terminal domain | 3 | 294 | 3.7E-36 | T | 22-09-2020 | IPR024571 | ERAP1-like C-terminal domain |
| UnnamedSample_HQ_transcript/23218|m.7742 | UnnamedSample_HQ_transcript/23218 | Coverage 0.372 too low. | f5112fbb64dc3773b78be71704395fa6 | 801 | Pfam | PF00757 | Furin-like cysteine rich region | 307 | 456 | 1.4E-25 | T | 22-09-2020 | IPR006211 | Furin-like cysteine-rich domain |
| UnnamedSample_HQ_transcript/23218|m.7742 | UnnamedSample_HQ_transcript/23218 | Coverage 0.372 too low. | f5112fbb64dc3773b78be71704395fa6 | 801 | Pfam | PF01030 | Receptor L domain | 166 | 277 | 2.3E-26 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/23218|m.7742 | UnnamedSample_HQ_transcript/23218 | Coverage 0.372 too low. | f5112fbb64dc3773b78be71704395fa6 | 801 | Pfam | PF01030 | Receptor L domain | 472 | 585 | 2.0E-25 | T | 22-09-2020 | IPR000494 | Receptor L-domain |
| UnnamedSample_HQ_transcript/65926|m.17192 | UnnamedSample_HQ_transcript/65926 | Coverage 0.174 too low. | ae9259e26d01b5084ac79a71344494af | 464 | Pfam | PF00067 | Cytochrome P450 | 41 | 397 | 1.2E-72 | T | 22-09-2020 | IPR001128 | Cytochrome P450 |
| UnnamedSample_HQ_transcript/405|m.315 | UnnamedSample_HQ_transcript/405 | Unmapped. | 8795c4dd0fc8d2b526ee699fe0b919a5 | 1143 | Pfam | PF13087 | AAA domain | 1 | 145 | 4.5E-18 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/277|m.233 | UnnamedSample_HQ_transcript/277 | Unmapped. | 8795c4dd0fc8d2b526ee699fe0b919a5 | 1143 | Pfam | PF13087 | AAA domain | 1 | 145 | 4.5E-18 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/78422|m.19447 | UnnamedSample_HQ_transcript/78422 | Coverage 0.427 too low. | 7c77bbc3239e8045e209062661d4ba83 | 474 | Pfam | PF08447 | PAS fold | 268 | 353 | 3.3E-15 | T | 22-09-2020 | IPR013655 | PAS fold-3 |
| UnnamedSample_HQ_transcript/78422|m.19447 | UnnamedSample_HQ_transcript/78422 | Coverage 0.427 too low. | 7c77bbc3239e8045e209062661d4ba83 | 474 | Pfam | PF00989 | PAS fold | 101 | 160 | 3.9E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/37738|m.11330 | UnnamedSample_HQ_transcript/37738 | Coverage 0.711 too low. | 952572e600b6a930f94640af1f6d1aa8 | 670 | Pfam | PF00439 | Bromodomain | 353 | 433 | 2.3E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/5791|m.2459 | UnnamedSample_HQ_transcript/5791 | Identity 0.495 too low. | 1cb1e7282044cfa5606886d0debd7509 | 1270 | Pfam | PF00780 | CNH domain | 963 | 1240 | 1.2E-61 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/5791|m.2459 | UnnamedSample_HQ_transcript/5791 | Identity 0.495 too low. | 1cb1e7282044cfa5606886d0debd7509 | 1270 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 9.7E-61 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/6247|m.2621 | UnnamedSample_HQ_transcript/6247 | Identity 0.482 too low. | 1cb1e7282044cfa5606886d0debd7509 | 1270 | Pfam | PF00780 | CNH domain | 963 | 1240 | 1.2E-61 | T | 22-09-2020 | IPR001180 | Citron homology (CNH) domain |
| UnnamedSample_HQ_transcript/6247|m.2621 | UnnamedSample_HQ_transcript/6247 | Identity 0.482 too low. | 1cb1e7282044cfa5606886d0debd7509 | 1270 | Pfam | PF00069 | Protein kinase domain | 25 | 289 | 9.7E-61 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/2716|m.1325 | UnnamedSample_HQ_transcript/2716 | Coverage 0.929 too low. | b75f6c04b7bc2d9c7c3a2b27c98350cb | 1654 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 81 | 225 | 2.0E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/2716|m.1325 | UnnamedSample_HQ_transcript/2716 | Coverage 0.929 too low. | b75f6c04b7bc2d9c7c3a2b27c98350cb | 1654 | Pfam | PF01751 | Toprim domain | 457 | 558 | 9.9E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/2716|m.1325 | UnnamedSample_HQ_transcript/2716 | Coverage 0.929 too low. | b75f6c04b7bc2d9c7c3a2b27c98350cb | 1654 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 718 | 1192 | 1.0E-128 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/2716|m.1325 | UnnamedSample_HQ_transcript/2716 | Coverage 0.929 too low. | b75f6c04b7bc2d9c7c3a2b27c98350cb | 1654 | Pfam | PF00204 | DNA gyrase B | 268 | 428 | 9.3E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/2716|m.1325 | UnnamedSample_HQ_transcript/2716 | Coverage 0.929 too low. | b75f6c04b7bc2d9c7c3a2b27c98350cb | 1654 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 573 | 716 | 1.3E-47 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/65889|m.17184 | UnnamedSample_HQ_transcript/65889 | Coverage 0.719 too low. | 7554e28b8be9a72970de40a807a10432 | 319 | Pfam | PF00611 | Fes/CIP4, and EFC/F-BAR homology domain | 10 | 86 | 1.7E-18 | T | 22-09-2020 | IPR001060 | FCH domain |
| UnnamedSample_HQ_transcript/90398|m.21313 | UnnamedSample_HQ_transcript/90398 | Coverage 0.870 too low. | e3fa6d52e8bc191f19c29da7c36a2307 | 389 | Pfam | PF00362 | Integrin beta chain VWA domain | 144 | 387 | 2.2E-113 | T | 22-09-2020 | IPR002369 | Integrin beta subunit, VWA domain |
| UnnamedSample_HQ_transcript/90398|m.21313 | UnnamedSample_HQ_transcript/90398 | Coverage 0.870 too low. | e3fa6d52e8bc191f19c29da7c36a2307 | 389 | Pfam | PF17205 | Integrin plexin domain | 36 | 67 | 5.7E-5 | T | 22-09-2020 | IPR033760 | Integrin beta N-terminal |
| UnnamedSample_HQ_transcript/85325|m.20551 | UnnamedSample_HQ_transcript/85325 | Coverage 0.830 too low. | e3fa6d52e8bc191f19c29da7c36a2307 | 389 | Pfam | PF00362 | Integrin beta chain VWA domain | 144 | 387 | 2.2E-113 | T | 22-09-2020 | IPR002369 | Integrin beta subunit, VWA domain |
| UnnamedSample_HQ_transcript/85325|m.20551 | UnnamedSample_HQ_transcript/85325 | Coverage 0.830 too low. | e3fa6d52e8bc191f19c29da7c36a2307 | 389 | Pfam | PF17205 | Integrin plexin domain | 36 | 67 | 5.7E-5 | T | 22-09-2020 | IPR033760 | Integrin beta N-terminal |
| UnnamedSample_HQ_transcript/28704|m.9140 | UnnamedSample_HQ_transcript/28704 | Coverage 0.859 too low. | 0fc6fba12d104199552066f50462dac5 | 428 | Pfam | PF00487 | Fatty acid desaturase | 146 | 349 | 2.1E-14 | T | 22-09-2020 | IPR005804 | Fatty acid desaturase domain |
| UnnamedSample_HQ_transcript/18056|m.6318 | UnnamedSample_HQ_transcript/18056 | Coverage 0.139 too low. | ca5755acbfa112506e48404a67cf6bd2 | 1043 | Pfam | PF00169 | PH domain | 51 | 149 | 1.5E-11 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/18056|m.6318 | UnnamedSample_HQ_transcript/18056 | Coverage 0.139 too low. | ca5755acbfa112506e48404a67cf6bd2 | 1043 | Pfam | PF00169 | PH domain | 334 | 429 | 1.8E-12 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/38517|m.11515 | UnnamedSample_HQ_transcript/38517 | Coverage 0.682 too low. | 4129050f1c38039473385465c96903da | 308 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/33791|m.10406 | UnnamedSample_HQ_transcript/33791 | Coverage 0.788 too low. | 4129050f1c38039473385465c96903da | 308 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/26933|m.8700 | UnnamedSample_HQ_transcript/26933 | Coverage 0.728 too low. | 4129050f1c38039473385465c96903da | 308 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/29768|m.9412 | UnnamedSample_HQ_transcript/29768 | Coverage 0.761 too low. | 4129050f1c38039473385465c96903da | 308 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/23791|m.7888 | UnnamedSample_HQ_transcript/23791 | Identity 0.904 too low. | 4129050f1c38039473385465c96903da | 308 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/43359|m.12570 | UnnamedSample_HQ_transcript/43359 | Coverage 0.724 too low. | 4129050f1c38039473385465c96903da | 308 | Pfam | PF00041 | Fibronectin type III domain | 96 | 180 | 1.6E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/11806|m.4425 | UnnamedSample_HQ_transcript/11806 | Coverage 0.885 too low. | 98aaf4d5250c4edc80e84893ea4bae77 | 875 | Pfam | PF00412 | LIM domain | 787 | 842 | 4.3E-11 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/11806|m.4425 | UnnamedSample_HQ_transcript/11806 | Coverage 0.885 too low. | 98aaf4d5250c4edc80e84893ea4bae77 | 875 | Pfam | PF00412 | LIM domain | 149 | 204 | 4.1E-13 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/95068|m.21966 | UnnamedSample_HQ_transcript/95068 | Coverage 0.928 too low. | 8d009cb66378d98a3730934427edc146 | 267 | Pfam | PF00135 | Carboxylesterase family | 15 | 252 | 6.6E-27 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/7397|m.2984 | UnnamedSample_HQ_transcript/7397 | Coverage 0.918 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/7535|m.3033 | UnnamedSample_HQ_transcript/7535 | Coverage 0.917 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/6322|m.2645 | UnnamedSample_HQ_transcript/6322 | Coverage 0.366 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/14832|m.5363 | UnnamedSample_HQ_transcript/14832 | Coverage 0.898 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/8262|m.3277 | UnnamedSample_HQ_transcript/8262 | Coverage 0.916 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/5503|m.2362 | UnnamedSample_HQ_transcript/5503 | Coverage 0.164 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/7242|m.2936 | UnnamedSample_HQ_transcript/7242 | Coverage 0.890 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/9229|m.3578 | UnnamedSample_HQ_transcript/9229 | Coverage 0.944 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/6710|m.2777 | UnnamedSample_HQ_transcript/6710 | Coverage 0.916 too low. | 4c9ae2589a51c193337d6e8829e1d559 | 724 | Pfam | PF03137 | Organic Anion Transporter Polypeptide (OATP) family | 92 | 664 | 5.8E-161 | T | 22-09-2020 | IPR004156 | Organic anion transporter polypeptide |
| UnnamedSample_HQ_transcript/76960|m.19198 | UnnamedSample_HQ_transcript/76960 | Coverage 0.805 too low. | 9881c06a71e621b2057d017a1410265e | 424 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/76960|m.19198 | UnnamedSample_HQ_transcript/76960 | Coverage 0.805 too low. | 9881c06a71e621b2057d017a1410265e | 424 | Pfam | PF00096 | Zinc finger, C2H2 type | 396 | 419 | 9.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/22952|m.7676 | UnnamedSample_HQ_transcript/22952 | Coverage 0.986 too low. | d1df0ba6f1391baec803d3709f43a3ce | 1002 | Pfam | PF05193 | Peptidase M16 inactive domain | 704 | 882 | 2.4E-9 | T | 22-09-2020 | IPR007863 | Peptidase M16, C-terminal |
| UnnamedSample_HQ_transcript/22952|m.7676 | UnnamedSample_HQ_transcript/22952 | Coverage 0.986 too low. | d1df0ba6f1391baec803d3709f43a3ce | 1002 | Pfam | PF05193 | Peptidase M16 inactive domain | 232 | 410 | 1.7E-24 | T | 22-09-2020 | IPR007863 | Peptidase M16, C-terminal |
| UnnamedSample_HQ_transcript/22952|m.7676 | UnnamedSample_HQ_transcript/22952 | Coverage 0.986 too low. | d1df0ba6f1391baec803d3709f43a3ce | 1002 | Pfam | PF16187 | Middle or third domain of peptidase_M16 | 416 | 699 | 3.8E-100 | T | 22-09-2020 | IPR032632 | Peptidase M16, middle/third domain |
| UnnamedSample_HQ_transcript/22952|m.7676 | UnnamedSample_HQ_transcript/22952 | Coverage 0.986 too low. | d1df0ba6f1391baec803d3709f43a3ce | 1002 | Pfam | PF00675 | Insulinase (Peptidase family M16) | 69 | 201 | 1.7E-38 | T | 22-09-2020 | IPR011765 | Peptidase M16, N-terminal |
| UnnamedSample_HQ_transcript/3627|m.1661 | UnnamedSample_HQ_transcript/3627 | Coverage 0.352 too low. | a87cf37d66cd0d6aa7f76dda0130ae5f | 893 | Pfam | PF00439 | Bromodomain | 343 | 415 | 3.1E-14 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/115281|m.24426 | UnnamedSample_HQ_transcript/115281 | Coverage 0.171 too low. | 97df33471ab4f26248ebec8378a7c3ac | 146 | Pfam | PF02961 | Barrier to autointegration factor | 3 | 44 | 2.0E-16 | T | 22-09-2020 | IPR004122 | Barrier- to-autointegration factor, BAF |
| UnnamedSample_HQ_transcript/115281|m.24426 | UnnamedSample_HQ_transcript/115281 | Coverage 0.171 too low. | 97df33471ab4f26248ebec8378a7c3ac | 146 | Pfam | PF01423 | LSM domain | 60 | 131 | 5.1E-18 | T | 22-09-2020 | IPR001163 | LSM domain, eukaryotic/archaea-type |
| UnnamedSample_HQ_transcript/30490|m.9583 | UnnamedSample_HQ_transcript/30490 | Unmapped. | 3c4bff08a9b213db129d1b399895e315 | 296 | Pfam | PF13087 | AAA domain | 126 | 271 | 1.3E-18 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/67830|m.17552 | UnnamedSample_HQ_transcript/67830 | Coverage 0.375 too low. | 2ebc1a2ebc00e94352626508650a272a | 433 | Pfam | PF12874 | Zinc-finger of C2H2 type | 238 | 256 | 0.024 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2935|m.1423 | UnnamedSample_HQ_transcript/2935 | Coverage 0.753 too low. | ab39fa0e57dc2f1083e50e3b0c9a6d0c | 1475 | Pfam | PF00498 | FHA domain | 216 | 273 | 3.0E-6 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/2935|m.1423 | UnnamedSample_HQ_transcript/2935 | Coverage 0.753 too low. | ab39fa0e57dc2f1083e50e3b0c9a6d0c | 1475 | Pfam | PF00595 | PDZ domain | 831 | 911 | 7.4E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2935|m.1423 | UnnamedSample_HQ_transcript/2935 | Coverage 0.753 too low. | ab39fa0e57dc2f1083e50e3b0c9a6d0c | 1475 | Pfam | PF01843 | DIL domain | 601 | 703 | 2.4E-30 | T | 22-09-2020 | IPR002710 | Dilute domain |
| UnnamedSample_HQ_transcript/2935|m.1423 | UnnamedSample_HQ_transcript/2935 | Coverage 0.753 too low. | ab39fa0e57dc2f1083e50e3b0c9a6d0c | 1475 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 27 | 137 | 9.5E-21 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/91796|m.21513 | UnnamedSample_HQ_transcript/91796 | Coverage 0.088 too low. | 4b5824311ca94ff7c23e90de82e7bc6e | 139 | Pfam | PF05902 | 4.1 protein C-terminal domain (CTD) | 33 | 133 | 8.5E-27 | T | 22-09-2020 | IPR008379 | Band 4.1, C-terminal |
| UnnamedSample_HQ_transcript/97463|m.22298 | UnnamedSample_HQ_transcript/97463 | Coverage 0.097 too low. | 4b5824311ca94ff7c23e90de82e7bc6e | 139 | Pfam | PF05902 | 4.1 protein C-terminal domain (CTD) | 33 | 133 | 8.5E-27 | T | 22-09-2020 | IPR008379 | Band 4.1, C-terminal |
| UnnamedSample_HQ_transcript/21085|m.7164 | UnnamedSample_HQ_transcript/21085 | Coverage 0.294 too low. | d25bb0033c3dcfb52311a4aced662bd4 | 895 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 439 | 522 | 3.7E-9 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/21085|m.7164 | UnnamedSample_HQ_transcript/21085 | Coverage 0.294 too low. | d25bb0033c3dcfb52311a4aced662bd4 | 895 | Pfam | PF00169 | PH domain | 568 | 673 | 1.9E-9 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/8295|m.3289 | UnnamedSample_HQ_transcript/8295 | Coverage 0.952 too low. | c053b990e221b70af472692028093fb4 | 824 | Pfam | PF04516 | CP2 transcription factor | 436 | 631 | 4.2E-54 | T | 22-09-2020 | IPR007604 | CP2 transcription factor |
| UnnamedSample_HQ_transcript/115867|m.24477 | UnnamedSample_HQ_transcript/115867 | Coverage 0.678 too low. | 1eac798f988e9acb55877f85181a9270 | 212 | Pfam | PF10502 | Signal peptidase, peptidase S26 | 37 | 107 | 4.5E-6 | T | 22-09-2020 | IPR019533 | Peptidase S26 |
| UnnamedSample_HQ_transcript/99451|m.22556 | UnnamedSample_HQ_transcript/99451 | Coverage 0.987 too low. | 816a64be30a9a5f6856f7909839480e2 | 235 | Pfam | PF12352 | Snare region anchored in the vesicle membrane C-terminus | 147 | 210 | 5.8E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/19127|m.6617 | UnnamedSample_HQ_transcript/19127 | Coverage 0.662 too low. | 53c0f5b35c11716fc1f8182d5e65dd52 | 321 | Pfam | PF00046 | Homeodomain | 231 | 287 | 2.8E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/15199|m.5463 | UnnamedSample_HQ_transcript/15199 | Coverage 0.990 too low. | 53c0f5b35c11716fc1f8182d5e65dd52 | 321 | Pfam | PF00046 | Homeodomain | 231 | 287 | 2.8E-20 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/49416|m.13892 | UnnamedSample_HQ_transcript/49416 | Coverage 0.935 too low. | 45e9ea3b2bc514a075c05d6b08e68f82 | 608 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 51 | 120 | 2.5E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/23279|m.7755 | UnnamedSample_HQ_transcript/23279 | Coverage 0.967 too low. | 2a4c138a359f15c15c8fc6c5ac3cd586 | 894 | Pfam | PF14765 | Polyketide synthase dehydratase | 529 | 728 | 4.1E-13 | T | 22-09-2020 | IPR020807 | Polyketide synthase, dehydratase domain |
| UnnamedSample_HQ_transcript/23279|m.7755 | UnnamedSample_HQ_transcript/23279 | Coverage 0.967 too low. | 2a4c138a359f15c15c8fc6c5ac3cd586 | 894 | Pfam | PF00698 | Acyl transferase domain | 167 | 466 | 4.3E-59 | T | 22-09-2020 | IPR014043 | Acyl transferase |
| UnnamedSample_HQ_transcript/23279|m.7755 | UnnamedSample_HQ_transcript/23279 | Coverage 0.967 too low. | 2a4c138a359f15c15c8fc6c5ac3cd586 | 894 | Pfam | PF16197 | Ketoacyl-synthetase C-terminal extension | 34 | 145 | 4.5E-33 | T | 22-09-2020 | IPR032821 | Polyketide synthase, C-terminal extension |
| UnnamedSample_HQ_transcript/23279|m.7755 | UnnamedSample_HQ_transcript/23279 | Coverage 0.967 too low. | 2a4c138a359f15c15c8fc6c5ac3cd586 | 894 | Pfam | PF02801 | Beta-ketoacyl synthase, C-terminal domain | 1 | 31 | 6.8E-5 | T | 22-09-2020 | IPR014031 | Beta-ketoacyl synthase, C-terminal |
| UnnamedSample_HQ_transcript/27793|m.8913 | UnnamedSample_HQ_transcript/27793 | Coverage 0.690 too low. | 53b994a87d7c67c6df099dada5d12946 | 575 | Pfam | PF19056 | WD40 repeated domain | 235 | 463 | 4.4E-61 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/27793|m.8913 | UnnamedSample_HQ_transcript/27793 | Coverage 0.690 too low. | 53b994a87d7c67c6df099dada5d12946 | 575 | Pfam | PF19057 | PH domain | 1 | 69 | 1.1E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/59035|m.15858 | UnnamedSample_HQ_transcript/59035 | Coverage 0.202 too low. | 06e60072ec0b3331cae5b5009b270814 | 547 | Pfam | PF00581 | Rhodanese-like domain | 389 | 495 | 1.7E-14 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/85572|m.20583 | UnnamedSample_HQ_transcript/85572 | Identity 0.926 too low. | 73814a1b37f1de2018270d7df2c33506 | 140 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 32 | 123 | 1.1E-18 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/78103|m.19389 | UnnamedSample_HQ_transcript/78103 | Coverage 0.347 too low. | 222056acbdd4d643742dbc0226b0fb52 | 396 | Pfam | PF01546 | Peptidase family M20/M25/M40 | 71 | 391 | 2.3E-36 | T | 22-09-2020 | IPR002933 | Peptidase M20 |
| UnnamedSample_HQ_transcript/78103|m.19389 | UnnamedSample_HQ_transcript/78103 | Coverage 0.347 too low. | 222056acbdd4d643742dbc0226b0fb52 | 396 | Pfam | PF07687 | Peptidase dimerisation domain | 183 | 294 | 1.7E-9 | T | 22-09-2020 | IPR011650 | Peptidase M20, dimerisation domain |
| UnnamedSample_HQ_transcript/83532|m.20270 | UnnamedSample_HQ_transcript/83532 | Coverage 0.384 too low. | a2f753f5af548b7f222c0a877694114d | 411 | Pfam | PF00069 | Protein kinase domain | 194 | 402 | 4.9E-58 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/83532|m.20270 | UnnamedSample_HQ_transcript/83532 | Coverage 0.384 too low. | a2f753f5af548b7f222c0a877694114d | 411 | Pfam | PF00615 | Regulator of G protein signaling domain | 58 | 176 | 7.2E-12 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/17775|m.6239 | UnnamedSample_HQ_transcript/17775 | Coverage 0.712 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 2.3E-67 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/17775|m.6239 | UnnamedSample_HQ_transcript/17775 | Coverage 0.712 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 560 | 584 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/17775|m.6239 | UnnamedSample_HQ_transcript/17775 | Coverage 0.712 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 462 | 493 | 0.1 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/17775|m.6239 | UnnamedSample_HQ_transcript/17775 | Coverage 0.712 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 590 | 626 | 0.0072 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20900|m.7122 | UnnamedSample_HQ_transcript/20900 | Coverage 0.567 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF03920 | Groucho/TLE N-terminal Q-rich domain | 20 | 143 | 2.3E-67 | T | 22-09-2020 | IPR005617 | Groucho/TLE, N-terminal Q-rich domain |
| UnnamedSample_HQ_transcript/20900|m.7122 | UnnamedSample_HQ_transcript/20900 | Coverage 0.567 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 560 | 584 | 0.16 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20900|m.7122 | UnnamedSample_HQ_transcript/20900 | Coverage 0.567 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 462 | 493 | 0.1 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20900|m.7122 | UnnamedSample_HQ_transcript/20900 | Coverage 0.567 too low. | 1bb56aa48c2eb09d87bf99fe3ddcf177 | 752 | Pfam | PF00400 | WD domain, G-beta repeat | 590 | 626 | 0.0072 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/18915|m.6557 | UnnamedSample_HQ_transcript/18915 | Coverage 0.153 too low. | 85434f16d37205491a55dd6d70debc75 | 942 | Pfam | PF13426 | PAS domain | 272 | 363 | 6.3E-9 | T | 22-09-2020 | IPR000014 | PAS domain |
| UnnamedSample_HQ_transcript/18915|m.6557 | UnnamedSample_HQ_transcript/18915 | Coverage 0.153 too low. | 85434f16d37205491a55dd6d70debc75 | 942 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 583 | 832 | 2.1E-82 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/1295|m.766 | UnnamedSample_HQ_transcript/1295 | Coverage 0.931 too low. | 799537697c6e4dc9d6e2a4c96ff7899e | 1962 | Pfam | PF02736 | Myosin N-terminal SH3-like domain | 36 | 75 | 5.1E-12 | T | 22-09-2020 | IPR004009 | Myosin, N-terminal, SH3-like |
| UnnamedSample_HQ_transcript/1295|m.766 | UnnamedSample_HQ_transcript/1295 | Coverage 0.931 too low. | 799537697c6e4dc9d6e2a4c96ff7899e | 1962 | Pfam | PF01576 | Myosin tail | 846 | 1923 | 6.5E-164 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/1295|m.766 | UnnamedSample_HQ_transcript/1295 | Coverage 0.931 too low. | 799537697c6e4dc9d6e2a4c96ff7899e | 1962 | Pfam | PF00063 | Myosin head (motor domain) | 90 | 766 | 4.7E-284 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF01414 | Delta serrate ligand | 178 | 240 | 1.5E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 389 | 418 | 2.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 351 | 380 | 1.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 543 | 575 | 1.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 311 | 341 | 6.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 427 | 459 | 8.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 467 | 496 | 5.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 505 | 534 | 5.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/19704|m.6787 | UnnamedSample_HQ_transcript/19704 | Coverage 0.345 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF07657 | N terminus of Notch ligand | 25 | 95 | 1.8E-23 | T | 22-09-2020 | IPR011651 | Notch ligand, N-terminal domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF01414 | Delta serrate ligand | 178 | 240 | 1.5E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 389 | 418 | 2.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 351 | 380 | 1.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 543 | 575 | 1.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 311 | 341 | 6.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 427 | 459 | 8.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 467 | 496 | 5.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 505 | 534 | 5.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/30578|m.9603 | UnnamedSample_HQ_transcript/30578 | Coverage 0.230 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF07657 | N terminus of Notch ligand | 25 | 95 | 1.8E-23 | T | 22-09-2020 | IPR011651 | Notch ligand, N-terminal domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF01414 | Delta serrate ligand | 178 | 240 | 1.5E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 389 | 418 | 2.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 351 | 380 | 1.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 543 | 575 | 1.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 311 | 341 | 6.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 427 | 459 | 8.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 467 | 496 | 5.9E-8 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 505 | 534 | 5.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/5212|m.2264 | UnnamedSample_HQ_transcript/5212 | Coverage 0.510 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF07657 | N terminus of Notch ligand | 25 | 95 | 1.8E-23 | T | 22-09-2020 | IPR011651 | Notch ligand, N-terminal domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF01414 | Delta serrate ligand | 178 | 240 | 1.5E-21 | T | 22-09-2020 | IPR001774 | Delta/Serrate/lag-2 (DSL) protein |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 389 | 418 | 2.9E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 351 | 380 | 1.8E-5 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 543 | 575 | 1.7E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
| UnnamedSample_HQ_transcript/22124|m.7464 | UnnamedSample_HQ_transcript/22124 | Coverage 0.310 too low. | f79ff8e0d16c95b3ae4b63cb6d8144e4 | 854 | Pfam | PF00008 | EGF-like domain | 311 | 341 | 6.2E-7 | T | 22-09-2020 | IPR000742 | EGF-like domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
